stella
beta
A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients — Stella
Home
/
Immune Checkpoint Inhibitors
/
View on ClinicalTrials.gov
Recruiting
Back to Immune Checkpoint Inhibitors trials
Trial locations
(1 site)
China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang